nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—FDPS—respiratory system—lung cancer	0.00529	0.211	CbGeAlD
Pamidronate—FDPS—bronchus—lung cancer	0.00436	0.174	CbGeAlD
Pamidronate—FDPS—trachea—lung cancer	0.00391	0.156	CbGeAlD
Pamidronate—FDPS—cardiac atrium—lung cancer	0.00367	0.147	CbGeAlD
Pamidronate—FDPS—bone marrow—lung cancer	0.0031	0.124	CbGeAlD
Pamidronate—FDPS—lung—lung cancer	0.00281	0.112	CbGeAlD
Pamidronate—Risedronate—PTGS2—lung cancer	0.0022	0.529	CrCbGaD
Pamidronate—Clodronate—PTGS2—lung cancer	0.00196	0.471	CrCbGaD
Pamidronate—FDPS—lymph node—lung cancer	0.00192	0.0767	CbGeAlD
Pamidronate—Somnolence—Etoposide—lung cancer	0.000359	0.00037	CcSEcCtD
Pamidronate—Cough—Docetaxel—lung cancer	0.000359	0.00037	CcSEcCtD
Pamidronate—Insomnia—Paclitaxel—lung cancer	0.000359	0.000369	CcSEcCtD
Pamidronate—Hypersensitivity—Irinotecan—lung cancer	0.000358	0.000369	CcSEcCtD
Pamidronate—Convulsion—Docetaxel—lung cancer	0.000357	0.000368	CcSEcCtD
Pamidronate—Paraesthesia—Paclitaxel—lung cancer	0.000356	0.000367	CcSEcCtD
Pamidronate—Hypertension—Docetaxel—lung cancer	0.000356	0.000366	CcSEcCtD
Pamidronate—Agranulocytosis—Methotrexate—lung cancer	0.000354	0.000365	CcSEcCtD
Pamidronate—Dyspnoea—Paclitaxel—lung cancer	0.000353	0.000364	CcSEcCtD
Pamidronate—Somnolence—Paclitaxel—lung cancer	0.000352	0.000363	CcSEcCtD
Pamidronate—Decreased appetite—Etoposide—lung cancer	0.000352	0.000362	CcSEcCtD
Pamidronate—Myalgia—Docetaxel—lung cancer	0.000351	0.000361	CcSEcCtD
Pamidronate—Arthralgia—Docetaxel—lung cancer	0.000351	0.000361	CcSEcCtD
Pamidronate—Nausea—Vinorelbine—lung cancer	0.00035	0.000361	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Etoposide—lung cancer	0.000349	0.00036	CcSEcCtD
Pamidronate—Dyspepsia—Paclitaxel—lung cancer	0.000349	0.00036	CcSEcCtD
Pamidronate—Body temperature increased—Cisplatin—lung cancer	0.000349	0.000359	CcSEcCtD
Pamidronate—Asthenia—Irinotecan—lung cancer	0.000349	0.000359	CcSEcCtD
Pamidronate—Fatigue—Etoposide—lung cancer	0.000349	0.000359	CcSEcCtD
Pamidronate—Constipation—Etoposide—lung cancer	0.000346	0.000356	CcSEcCtD
Pamidronate—Pain—Etoposide—lung cancer	0.000346	0.000356	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—lung cancer	0.000345	0.000355	CcSEcCtD
Pamidronate—Decreased appetite—Paclitaxel—lung cancer	0.000345	0.000355	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000343	0.000353	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—lung cancer	0.000343	0.000353	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000342	0.000353	CcSEcCtD
Pamidronate—Fatigue—Paclitaxel—lung cancer	0.000342	0.000352	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—lung cancer	0.000341	0.000351	CcSEcCtD
Pamidronate—Asthenia—Gemcitabine—lung cancer	0.00034	0.00035	CcSEcCtD
Pamidronate—Pain—Paclitaxel—lung cancer	0.000339	0.000349	CcSEcCtD
Pamidronate—Constipation—Paclitaxel—lung cancer	0.000339	0.000349	CcSEcCtD
Pamidronate—Confusional state—Docetaxel—lung cancer	0.000339	0.000349	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—lung cancer	0.000337	0.000347	CcSEcCtD
Pamidronate—Oedema—Docetaxel—lung cancer	0.000336	0.000346	CcSEcCtD
Pamidronate—Anaphylactic shock—Docetaxel—lung cancer	0.000336	0.000346	CcSEcCtD
Pamidronate—Pruritus—Gemcitabine—lung cancer	0.000335	0.000345	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—lung cancer	0.000334	0.000344	CcSEcCtD
Pamidronate—Infection—Docetaxel—lung cancer	0.000334	0.000344	CcSEcCtD
Pamidronate—Feeling abnormal—Etoposide—lung cancer	0.000333	0.000343	CcSEcCtD
Pamidronate—Diarrhoea—Irinotecan—lung cancer	0.000333	0.000343	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—lung cancer	0.000331	0.000341	CcSEcCtD
Pamidronate—Gastrointestinal pain—Etoposide—lung cancer	0.000331	0.000341	CcSEcCtD
Pamidronate—Shock—Docetaxel—lung cancer	0.000331	0.000341	CcSEcCtD
Pamidronate—Nervous system disorder—Docetaxel—lung cancer	0.00033	0.00034	CcSEcCtD
Pamidronate—Thrombocytopenia—Docetaxel—lung cancer	0.000329	0.000339	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—lung cancer	0.000329	0.000339	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—lung cancer	0.000329	0.000339	CcSEcCtD
Pamidronate—Tachycardia—Docetaxel—lung cancer	0.000328	0.000338	CcSEcCtD
Pamidronate—Feeling abnormal—Paclitaxel—lung cancer	0.000327	0.000337	CcSEcCtD
Pamidronate—Hypersensitivity—Cisplatin—lung cancer	0.000325	0.000335	CcSEcCtD
Pamidronate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000324	0.000334	CcSEcCtD
Pamidronate—Diarrhoea—Gemcitabine—lung cancer	0.000324	0.000334	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—lung cancer	0.000323	0.000333	CcSEcCtD
Pamidronate—Dizziness—Irinotecan—lung cancer	0.000321	0.000331	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—lung cancer	0.000321	0.00033	CcSEcCtD
Pamidronate—Anorexia—Docetaxel—lung cancer	0.00032	0.00033	CcSEcCtD
Pamidronate—Body temperature increased—Etoposide—lung cancer	0.00032	0.000329	CcSEcCtD
Pamidronate—Abdominal pain—Etoposide—lung cancer	0.00032	0.000329	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—lung cancer	0.00032	0.000329	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—lung cancer	0.00032	0.000329	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—lung cancer	0.000319	0.000328	CcSEcCtD
Pamidronate—Asthenia—Cisplatin—lung cancer	0.000317	0.000326	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—lung cancer	0.000316	0.000326	CcSEcCtD
Pamidronate—Hypotension—Docetaxel—lung cancer	0.000314	0.000323	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—lung cancer	0.000314	0.000323	CcSEcCtD
Pamidronate—Abdominal pain—Paclitaxel—lung cancer	0.000313	0.000323	CcSEcCtD
Pamidronate—Body temperature increased—Paclitaxel—lung cancer	0.000313	0.000323	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—lung cancer	0.000309	0.000319	CcSEcCtD
Pamidronate—Vomiting—Irinotecan—lung cancer	0.000309	0.000318	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—lung cancer	0.000309	0.000318	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—lung cancer	0.000308	0.000317	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—lung cancer	0.000307	0.000317	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—lung cancer	0.000307	0.000316	CcSEcCtD
Pamidronate—Rash—Irinotecan—lung cancer	0.000307	0.000316	CcSEcCtD
Pamidronate—Dermatitis—Irinotecan—lung cancer	0.000306	0.000315	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000306	0.000315	CcSEcCtD
Pamidronate—Chills—Methotrexate—lung cancer	0.000306	0.000315	CcSEcCtD
Pamidronate—Headache—Irinotecan—lung cancer	0.000305	0.000314	CcSEcCtD
Pamidronate—Insomnia—Docetaxel—lung cancer	0.000304	0.000313	CcSEcCtD
Pamidronate—Diarrhoea—Cisplatin—lung cancer	0.000302	0.000311	CcSEcCtD
Pamidronate—Paraesthesia—Docetaxel—lung cancer	0.000302	0.000311	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—lung cancer	0.000301	0.00031	CcSEcCtD
Pamidronate—Vomiting—Gemcitabine—lung cancer	0.000301	0.00031	CcSEcCtD
Pamidronate—Dyspnoea—Docetaxel—lung cancer	0.0003	0.000309	CcSEcCtD
Pamidronate—Somnolence—Docetaxel—lung cancer	0.000299	0.000308	CcSEcCtD
Pamidronate—Rash—Gemcitabine—lung cancer	0.000299	0.000308	CcSEcCtD
Pamidronate—Dermatitis—Gemcitabine—lung cancer	0.000298	0.000307	CcSEcCtD
Pamidronate—Hypersensitivity—Etoposide—lung cancer	0.000298	0.000307	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—lung cancer	0.000297	0.000306	CcSEcCtD
Pamidronate—Erythema—Methotrexate—lung cancer	0.000297	0.000306	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—lung cancer	0.000297	0.000306	CcSEcCtD
Pamidronate—Headache—Gemcitabine—lung cancer	0.000297	0.000306	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—lung cancer	0.000296	0.000305	CcSEcCtD
Pamidronate—Dyspepsia—Docetaxel—lung cancer	0.000296	0.000305	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—lung cancer	0.000295	0.000304	CcSEcCtD
Pamidronate—Decreased appetite—Docetaxel—lung cancer	0.000292	0.000301	CcSEcCtD
Pamidronate—Hypersensitivity—Paclitaxel—lung cancer	0.000292	0.000301	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—lung cancer	0.000292	0.0003	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—lung cancer	0.000291	0.000299	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Docetaxel—lung cancer	0.00029	0.000299	CcSEcCtD
Pamidronate—Asthenia—Etoposide—lung cancer	0.00029	0.000299	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—lung cancer	0.00029	0.000299	CcSEcCtD
Pamidronate—Fatigue—Docetaxel—lung cancer	0.00029	0.000298	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—lung cancer	0.000289	0.000298	CcSEcCtD
Pamidronate—Nausea—Irinotecan—lung cancer	0.000289	0.000297	CcSEcCtD
Pamidronate—Constipation—Docetaxel—lung cancer	0.000287	0.000296	CcSEcCtD
Pamidronate—Pain—Docetaxel—lung cancer	0.000287	0.000296	CcSEcCtD
Pamidronate—Back pain—Methotrexate—lung cancer	0.000287	0.000296	CcSEcCtD
Pamidronate—Pruritus—Etoposide—lung cancer	0.000286	0.000295	CcSEcCtD
Pamidronate—Asthenia—Paclitaxel—lung cancer	0.000284	0.000293	CcSEcCtD
Pamidronate—Nausea—Gemcitabine—lung cancer	0.000281	0.00029	CcSEcCtD
Pamidronate—Vomiting—Cisplatin—lung cancer	0.000281	0.000289	CcSEcCtD
Pamidronate—Pruritus—Paclitaxel—lung cancer	0.000281	0.000289	CcSEcCtD
Pamidronate—Rash—Cisplatin—lung cancer	0.000278	0.000287	CcSEcCtD
Pamidronate—Dermatitis—Cisplatin—lung cancer	0.000278	0.000286	CcSEcCtD
Pamidronate—Feeling abnormal—Docetaxel—lung cancer	0.000277	0.000285	CcSEcCtD
Pamidronate—Diarrhoea—Etoposide—lung cancer	0.000277	0.000285	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—lung cancer	0.000276	0.000284	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—lung cancer	0.000275	0.000284	CcSEcCtD
Pamidronate—Gastrointestinal pain—Docetaxel—lung cancer	0.000275	0.000283	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—lung cancer	0.000274	0.000283	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—lung cancer	0.000274	0.000282	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—lung cancer	0.000274	0.000282	CcSEcCtD
Pamidronate—Diarrhoea—Paclitaxel—lung cancer	0.000271	0.000279	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—lung cancer	0.000268	0.000276	CcSEcCtD
Pamidronate—Malaise—Methotrexate—lung cancer	0.000268	0.000276	CcSEcCtD
Pamidronate—Dizziness—Etoposide—lung cancer	0.000267	0.000275	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—lung cancer	0.000267	0.000275	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—lung cancer	0.000266	0.000274	CcSEcCtD
Pamidronate—Abdominal pain—Docetaxel—lung cancer	0.000266	0.000274	CcSEcCtD
Pamidronate—Body temperature increased—Docetaxel—lung cancer	0.000266	0.000274	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—lung cancer	0.000266	0.000274	CcSEcCtD
Pamidronate—Chills—Doxorubicin—lung cancer	0.000265	0.000273	CcSEcCtD
Pamidronate—Dizziness—Paclitaxel—lung cancer	0.000262	0.00027	CcSEcCtD
Pamidronate—Nausea—Cisplatin—lung cancer	0.000262	0.00027	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—lung cancer	0.000261	0.000269	CcSEcCtD
Pamidronate—Cough—Methotrexate—lung cancer	0.000259	0.000267	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—lung cancer	0.000257	0.000265	CcSEcCtD
Pamidronate—Vomiting—Etoposide—lung cancer	0.000257	0.000265	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—lung cancer	0.000257	0.000265	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—lung cancer	0.000257	0.000265	CcSEcCtD
Pamidronate—Rash—Etoposide—lung cancer	0.000255	0.000263	CcSEcCtD
Pamidronate—Dermatitis—Etoposide—lung cancer	0.000255	0.000262	CcSEcCtD
Pamidronate—Headache—Etoposide—lung cancer	0.000253	0.000261	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—lung cancer	0.000253	0.00026	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—lung cancer	0.000253	0.00026	CcSEcCtD
Pamidronate—Tension—Doxorubicin—lung cancer	0.000252	0.00026	CcSEcCtD
Pamidronate—Vomiting—Paclitaxel—lung cancer	0.000252	0.00026	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—lung cancer	0.000252	0.000259	CcSEcCtD
Pamidronate—Rash—Paclitaxel—lung cancer	0.00025	0.000258	CcSEcCtD
Pamidronate—Dermatitis—Paclitaxel—lung cancer	0.00025	0.000257	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—lung cancer	0.00025	0.000257	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—lung cancer	0.00025	0.000257	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—lung cancer	0.000249	0.000256	CcSEcCtD
Pamidronate—Headache—Paclitaxel—lung cancer	0.000248	0.000256	CcSEcCtD
Pamidronate—Hypersensitivity—Docetaxel—lung cancer	0.000248	0.000255	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—lung cancer	0.000247	0.000255	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—lung cancer	0.000244	0.000252	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—lung cancer	0.000242	0.00025	CcSEcCtD
Pamidronate—Asthenia—Docetaxel—lung cancer	0.000241	0.000248	CcSEcCtD
Pamidronate—Infection—Methotrexate—lung cancer	0.000241	0.000248	CcSEcCtD
Pamidronate—Nausea—Etoposide—lung cancer	0.00024	0.000247	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—lung cancer	0.000238	0.000246	CcSEcCtD
Pamidronate—Pruritus—Docetaxel—lung cancer	0.000238	0.000245	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—lung cancer	0.000238	0.000245	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—lung cancer	0.000238	0.000245	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—lung cancer	0.000237	0.000244	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—lung cancer	0.000236	0.000243	CcSEcCtD
Pamidronate—Nausea—Paclitaxel—lung cancer	0.000236	0.000243	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—lung cancer	0.000234	0.000241	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—lung cancer	0.000232	0.000239	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—lung cancer	0.000231	0.000238	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—lung cancer	0.00023	0.000237	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—lung cancer	0.00023	0.000237	CcSEcCtD
Pamidronate—Diarrhoea—Docetaxel—lung cancer	0.00023	0.000237	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—lung cancer	0.000226	0.000233	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—lung cancer	0.000226	0.000233	CcSEcCtD
Pamidronate—Cough—Doxorubicin—lung cancer	0.000224	0.000231	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—lung cancer	0.000223	0.000229	CcSEcCtD
Pamidronate—Dizziness—Docetaxel—lung cancer	0.000222	0.000229	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—lung cancer	0.000222	0.000229	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000221	0.000227	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—lung cancer	0.000219	0.000226	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—lung cancer	0.000219	0.000225	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—lung cancer	0.000219	0.000225	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—lung cancer	0.000218	0.000225	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—lung cancer	0.000218	0.000224	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—lung cancer	0.000216	0.000223	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—lung cancer	0.000216	0.000222	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—lung cancer	0.000215	0.000222	CcSEcCtD
Pamidronate—Vomiting—Docetaxel—lung cancer	0.000214	0.00022	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—lung cancer	0.000213	0.00022	CcSEcCtD
Pamidronate—Rash—Docetaxel—lung cancer	0.000212	0.000218	CcSEcCtD
Pamidronate—Dermatitis—Docetaxel—lung cancer	0.000212	0.000218	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—lung cancer	0.000211	0.000218	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—lung cancer	0.000211	0.000217	CcSEcCtD
Pamidronate—Headache—Docetaxel—lung cancer	0.000211	0.000217	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—lung cancer	0.00021	0.000216	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—lung cancer	0.00021	0.000216	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—lung cancer	0.000209	0.000215	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—lung cancer	0.000209	0.000215	CcSEcCtD
Pamidronate—Infection—Doxorubicin—lung cancer	0.000208	0.000215	CcSEcCtD
Pamidronate—Pain—Methotrexate—lung cancer	0.000207	0.000213	CcSEcCtD
Pamidronate—Shock—Doxorubicin—lung cancer	0.000206	0.000213	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—lung cancer	0.000206	0.000212	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—lung cancer	0.000205	0.000212	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—lung cancer	0.000205	0.000211	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—lung cancer	0.000203	0.000209	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—lung cancer	0.0002	0.000206	CcSEcCtD
Pamidronate—Nausea—Docetaxel—lung cancer	0.0002	0.000206	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—lung cancer	0.0002	0.000206	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—lung cancer	0.000198	0.000204	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—lung cancer	0.000196	0.000202	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—lung cancer	0.000191	0.000197	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—lung cancer	0.000191	0.000197	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000191	0.000197	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—lung cancer	0.00019	0.000195	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—lung cancer	0.000188	0.000194	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—lung cancer	0.000187	0.000193	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—lung cancer	0.000186	0.000192	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—lung cancer	0.000185	0.00019	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—lung cancer	0.000182	0.000188	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000181	0.000187	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—lung cancer	0.000181	0.000186	CcSEcCtD
Pamidronate—Pain—Doxorubicin—lung cancer	0.000179	0.000185	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—lung cancer	0.000179	0.000185	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—lung cancer	0.000178	0.000184	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—lung cancer	0.000174	0.000179	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—lung cancer	0.000173	0.000178	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—lung cancer	0.000172	0.000177	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—lung cancer	0.000171	0.000177	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—lung cancer	0.000166	0.000171	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—lung cancer	0.000166	0.000171	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—lung cancer	0.000166	0.000171	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—lung cancer	0.00016	0.000165	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—lung cancer	0.000155	0.000159	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—lung cancer	0.000154	0.000159	CcSEcCtD
Pamidronate—Rash—Methotrexate—lung cancer	0.000153	0.000157	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—lung cancer	0.000153	0.000157	CcSEcCtD
Pamidronate—Headache—Methotrexate—lung cancer	0.000152	0.000156	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—lung cancer	0.00015	0.000155	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—lung cancer	0.000148	0.000153	CcSEcCtD
Pamidronate—Nausea—Methotrexate—lung cancer	0.000144	0.000148	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—lung cancer	0.000144	0.000148	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—lung cancer	0.000139	0.000143	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—lung cancer	0.000133	0.000137	CcSEcCtD
Pamidronate—Rash—Doxorubicin—lung cancer	0.000132	0.000136	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—lung cancer	0.000132	0.000136	CcSEcCtD
Pamidronate—Headache—Doxorubicin—lung cancer	0.000131	0.000135	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—lung cancer	0.000125	0.000128	CcSEcCtD
